Vascutek Anaconda™ Abdominal Aortic Aneurysm (AAA) Post-Market Surveillance Registry
NCT ID: NCT01744119
Last Updated: 2016-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
318 participants
OBSERVATIONAL
2005-04-30
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Vascutek Custom Fenestrated Anaconda Post-Market Surveillance Study
NCT01826344
Study of Abdominal Aortic Stent Grafts in the Treatment of Infrarenal Abdominal Aortic Aneurysms
NCT01783184
Global Fenestrated Anaconda Clinical STudy
NCT03180996
The Study of the Fenestrated Anaconda Device in the Treatment of Abdominal Aortic Aneurysms
NCT04592185
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
NCT06218875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The system is available in a wide range of sizes thus making it a flexible and adaptable stent graft system with the potential to repair diverse patient anatomy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abdominal Aortic Aneurysm
Vascutek Anaconda™ Stent Graft System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vascutek Anaconda™ Stent Graft System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Juxta or Suprarenal extension of aneurysm
* Clinically serious concomitant medical disease or infection
* Need to sacrifice both Internal Iliac Arteries due to aneurysmal dilatation
* Connective Tissue Disease (Marfan's Syndrome)
* ASA Rating of Grade IV or V
* Known allergy to Nitinol, Polyester or contrast medium
* Excessive tortuosity of access vessels (femoral or iliac arteries)
* Patients with aneurysm neck lengths of less than 15mm
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vascutek Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dalcross Private Hospital
Killara, New South Wales, Australia
Newcastle Private Medical Suites
Newcastle, New South Wales, Australia
Westmead Hospital
Westmead, New South Wales, Australia
The Austin Hospital
Heidelberg, Victoria, Australia
Geelong Regional Vascular Service
Geelong, , Australia
Royal Perth Hospital
Perth, , Australia
Hollywood, Royal Perth
Perth, , Australia
Clinique Guillaume De Varye
Saint-Doulchard, , France
DRK Kliniken Mark Brandenburg
Berlin, , Germany
Dresden-Friedrichstadt
Dresden, , Germany
Klinikum Grosshadern
Munich, , Germany
San Orsola - Bologna University
Bologna, , Italy
University federico II
Naples, , Italy
Guglielmo da Saliceto
Piacenza, , Italy
Casa di Cura Nuova Itor
Roma, , Italy
Christchurch Hospital, CDHB
Christchurch, , New Zealand
Waikato Hospital
Hamilton, , New Zealand
Hospital Universitario Madrid Monteprincipe
Madrid, , Spain
Royal Derby Hospital
Derby, , United Kingdom
Gartnavel General Hospital
Glasgow, , United Kingdom
Wishaw General Hospital
Wishaw, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANA-PMS001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.